Pages that link to "Q28196845"
Jump to navigation
Jump to search
The following pages link to Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents (Q28196845):
Displaying 20 items.
- (Q28164745) (redirect page) (← links)
- Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation (Q30437086) (← links)
- Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection (Q30450509) (← links)
- Deficiency of Atf3, an adaptive-response gene, protects islets and ameliorates inflammation in a syngeneic mouse transplantation model. (Q33882136) (← links)
- Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines (Q34292905) (← links)
- Eicosanoids, β-cell function, and diabetes (Q35129888) (← links)
- Pro-inflammatory and pro-oxidant status of pancreatic islet in vitro is controlled by TLR-4 and HO-1 pathways (Q35364286) (← links)
- Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways (Q35793015) (← links)
- Thinking bedside at the bench: the NOD mouse model of T1DM. (Q35911875) (← links)
- Challenges and emerging technologies in the immunoisolation of cells and tissues (Q37006047) (← links)
- Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics (Q37404257) (← links)
- Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus (Q37832964) (← links)
- Altered monocyte cyclo-oxygenase response in non-obese diabetic mice (Q42445681) (← links)
- Effects of Cyclooxygenase-2 Inhibitor and Adenosine Triphosphate–Sensitive Potassium Channel Opener in Syngeneic Mouse Islet Transplantation (Q42776160) (← links)
- Interferon regulatory factor-1 is a key transcription factor in murine beta cells under immune attack (Q43276183) (← links)
- Co-expression of vascular endothelial growth factor and interleukin-1 receptor antagonist improves human islet survival and function (Q45861718) (← links)
- Interleukin-1 receptor antagonist enhances islet engraftment without impacting serum levels of nitrite or osteopontin. (Q45958470) (← links)
- Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. (Q47622122) (← links)
- Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes (Q83960155) (← links)
- 1,25(OH)2D3 prolongs islet graft survival by inflammatory inhibition (Q88092023) (← links)